Attitudes toward HPV Vaccination among Women Aged 27 to 45
Author Information
Author(s): Thomas W. Weiss, Susan L. Rosenthal, Gregory D. Zimet
Primary Institution: Merck & Co., Inc.
Hypothesis
What are the attitudes of US women aged 27 to 45 toward HPV vaccination?
Conclusion
Most women aged 27 to 45 felt the HPV vaccine was relevant to them and were likely to consider vaccination if it became available.
Supporting Evidence
- 67.4% of respondents reported that the HPV vaccine was relevant to them.
- 62.8% cited protection from cervical cancer as a reason for relevance.
- 71.1% of women who found the vaccine relevant were likely or extremely likely to get vaccinated.
Takeaway
This study asked women aged 27 to 45 if they thought the HPV vaccine was important, and many said yes, especially because it can help prevent cancer.
Methodology
A survey was mailed to 2,750 insured US women to assess their attitudes toward HPV vaccination.
Potential Biases
Geographic imbalance in respondents may have introduced bias.
Limitations
The study had a low response rate and may not be generalizable to uninsured women or those outside the US.
Participant Demographics
Predominantly white (84.0%), married (75.6%), and employed fulltime (67.8%), with a mean age of 36.8.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website